Month: September 2020

LAS VEGAS, NV, Sept. 29, 2020 (GLOBE NEWSWIRE) — via NewMediaWire –ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company, is pleased to announce that its recently launched telehealth subsidiary, Telecare Home Health, LLC (“Telecare”), has received its license from the State of Texas under Chapter 142 of the Texas Health and Safety Code to operate in Texas. In addition, the process of review toward accreditation is now underway for Telecare.“Telehealth has become one of the most important growing innovations to emerge as a mainstream facet of the healthcare system over recent months, and we intend Telecare to become a key player in this narrative,” noted Alonzo Pierce, President and Chairman of ISW Holdings. “Telecare’s platform is built from the ground up to key off of...

CAMBRIDGE, Mass. and NEW YORK, Sept. 29, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the appointment of Robert A. Ingram as the Chairman of its Board of Directors. Brad Bolzon, Ph.D., Chairman and Managing Director at Versant Ventures and Black Diamond’s founding Chairman, will remain on the Company’s board.“As we welcome Bob to his new role, I would like to thank Brad for the integral role he played as Chairman of the Board of Black Diamond from our founding with Versant through our transition to a public company, and I’m very happy that he will continue to help guide the company as a director,” said David M. Epstein, Ph.D., President and Chief Executive Officer...

FORT LAUDERDALE, Fla., Sept. 29, 2020 (GLOBE NEWSWIRE) — via NetworkWire – The Movie Studio, Inc. (OTC: MVES) (the “Company”) announces it has engaged Digital Talent Studio, Inc. and social media mogul Brian Breach, of Sikey Corp., for social media branding, engagement of influencers, and advertising on key social media platforms preparatory to the upcoming launch of The Movie Studio App. In addition to social media ad placement strategies targeting relevant demographics to promote the Company’s app, high-profile social media influencers will be engaged to participate in distributing the ads in a pay or revenue-sharing agreement and will also have opportunities for potential casting in the Company’s in-production “Moviesodes.”A beta version of The Movie Studio App is currently available for download in the Google Play Store and...

BAKERSFIELD, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ:LGIH) today announced their entrance into the Bakersfield, California market with the opening of their newest community, Juliana’s Garden. This marks the company’s growth into its fourth market in the state of California.“We have seen strong demand in the Bakersfield market and are pleased to offer homebuyers in this area an affordable alternative to renting,” said Chris Kelly, LGI Homes’ division president. “With owning a home becoming more important now, than ever, we believe Juliana’s Garden is the perfect location for those looking for a quality, upgraded home near everyday conveniences.”Ideally situated off California State Route 178, the beautiful community of Juliana’s Garden offers homebuyers in the Bakersfield area a once-in-a-lifetime opportunity...

Press releaseSynairgen plc(‘Synairgen’ or the ‘Company’)Interim results for the six months ended 30 June 2020Southampton, UK – 29 September 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces its unaudited interim results for the six months ended 30 June 2020.Highlights (including post period-end)OperationalPositive results from SG016, its double-blind placebo-controlled Phase II trial of SNG001 in hospitalised COVID-19 patients announced in July The Company extended the SG016 Phase II trial to include a further 120 patients with confirmed COVID-19 to be dosed in the home environment (ongoing) Positive results from interim analysis of SG015, its double-blind placebo-controlled Phase II trial of SNG001 in COPD patients announced in September, supporting the COVID-19 programme Patent applications...

OTTAWA, Sept. 29, 2020 (GLOBE NEWSWIRE) — ProntoForms Corporation (TSXV: PFM), the global leader in field-focused low-code application platforms for enterprise announced today their free virtual user conference, EMPOWER’20, on October 7th for partners, prospects, investors, and customers.The EMPOWER conference was created in 2019 as part of ProntoForms’ commitment to facilitating customer input in both the product roadmap and growth of the platform. This year, the EMPOWER’20 user conference has gone virtual, decreasing barriers to entry and allowing for a larger and more diverse set of attendees. Sessions will feature Fortune 500 field service leaders, industry analysts, and ProntoForms product experts.The conference is divided into three talk tracks based on the three key elements of a field organization that ProntoForms’ low-code...

Summit Therapeutics Inc.(‘Summit’, the ‘Company’ or the ‘Group’)Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020Cambridge, MA, September 29, 2020 – Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on its operational progress for the second quarter and six months ended June 30, 2020.Ridinilazole for C. difficile Infection (‘CDI’)Summit published data from its Phase 2 clinical trial of ridinilazole evaluating the effects of a narrow-spectrum (ridinilazole) or broad-spectrum antibiotic (vancomycin) on intestinal bile acid profiles. This was the first study to demonstrate in humans the relationships between Clostridioides difficile antibiotic treatment choice and bile acid metabolism both during therapy and...